Clinical Trial Update: Pharmacokinetic Parameters of Co-trimoxazole [Phase 2]

View source ↗

Summary

This update presents pharmacokinetic parameters for co-trimoxazole evaluated in a Phase 2 study for tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Co-trimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED